178 related articles for article (PubMed ID: 20172447)
1. Dendritic cells loaded with ultrasound-ablated tumour induce in vivo specific antitumour immune responses.
Deng J; Zhang Y; Feng J; Wu F
Ultrasound Med Biol; 2010 Mar; 36(3):441-8. PubMed ID: 20172447
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound.
Zhang Y; Deng J; Feng J; Wu F
World J Gastroenterol; 2010 Jul; 16(28):3584-91. PubMed ID: 20653069
[TBL] [Abstract][Full Text] [Related]
3. High-intensity focused ultrasound tumor ablation activates autologous tumor-specific cytotoxic T lymphocytes.
Xia JZ; Xie FL; Ran LF; Xie XP; Fan YM; Wu F
Ultrasound Med Biol; 2012 Aug; 38(8):1363-71. PubMed ID: 22633269
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of antitumor effects of dendritic cells modified with different forms of hepatocellular cancer antigens].
He LX; Zhang GM; Feng ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):100-2, 117. PubMed ID: 15629095
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
Weigel BJ; Panoskaltsis-Mortari A; Diers M; Garcia M; Lees C; Krieg AM; Chen W; Blazar BR
Exp Hematol; 2006 Oct; 34(10):1403-12. PubMed ID: 16982333
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12.
Tamaki S; Homma S; Enomoto Y; Komita H; Zeniya M; Ohno T; Toda G
Clin Immunol; 2005 Dec; 117(3):280-93. PubMed ID: 16246626
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.
Hayashi T; Nakao K; Nagayama Y; Saitoh O; Ichikawa T; Ishikawa H; Hamasaki K; Eguchi K; Ishii N
Int J Oncol; 2005 May; 26(5):1313-9. PubMed ID: 15809723
[TBL] [Abstract][Full Text] [Related]
8. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
9. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
Gao J; Chen M; Peng ML; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
[TBL] [Abstract][Full Text] [Related]
10. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model.
Jouanneau E; Poujol D; Gulia S; Le Mercier I; Blay JY; Belin MF; Puisieux I
Cancer Immunol Immunother; 2006 Mar; 55(3):254-67. PubMed ID: 16133115
[TBL] [Abstract][Full Text] [Related]
12. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of immunization with fusion of dendritic cells and hepatocellular carcinoma cells in mice.
Zhang H; Zheng SS; Jiang GP; Wu LH; Zhu F; Yang ZL
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):235-40. PubMed ID: 15138117
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells.
Ogawa F; Iinuma H; Okinaga K
Scand J Immunol; 2004 May; 59(5):432-9. PubMed ID: 15140052
[TBL] [Abstract][Full Text] [Related]
15. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.
Xu ZL; Zhu XQ; Lu P; Zhou Q; Zhang J; Wu F
Ultrasound Med Biol; 2009 Jan; 35(1):50-7. PubMed ID: 18950932
[TBL] [Abstract][Full Text] [Related]
16. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
Sun K; Wang L; Zhang Y
Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
[TBL] [Abstract][Full Text] [Related]
18. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
[TBL] [Abstract][Full Text] [Related]
19. Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA.
Teramoto K; Kontani K; Fujita T; Ozaki Y; Sawai S; Tezuka N; Fujino S; Itoh Y; Taguchi O; Kannagi R; Ogasawara K
Cancer Immunol Immunother; 2007 Mar; 56(3):331-42. PubMed ID: 16896967
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
